BD Names Gregory J. Hayes to Board of Directors
BD (NYSE: BDX) has appointed Gregory J. Hayes to its board of directors, effective March 26, 2025. Hayes, 64, currently serves as executive chairman of RTX and brings over 30 years of executive experience. This appointment aligns with BD's transformation strategy, particularly as the company prepares for the planned separation of its Diagnostic Solutions and Biosciences business.
Hayes' extensive background includes CEO and senior leadership roles in finance, corporate strategy, and business development. At United Technologies (UTC), he served as CEO from 2014 and chairman from 2016, playing a key role in the 2020 merger that formed RTX. He previously served as UTC's CFO from 2008 to 2014.
Hayes is the fourth independent director added to BD's board since 2021, demonstrating the company's commitment to board refreshment and strong corporate governance.
BD (NYSE: BDX) ha nominato Gregory J. Hayes nel suo consiglio di amministrazione, con effetto dal 26 marzo 2025. Hayes, 64 anni, attualmente ricopre il ruolo di presidente esecutivo di RTX e porta con sé oltre 30 anni di esperienza dirigenziale. Questa nomina è in linea con la strategia di trasformazione di BD, soprattutto mentre l'azienda si prepara per la prevista separazione delle sue attività di Soluzioni Diagnostiche e Bioscienze.
Il vasto background di Hayes include ruoli di CEO e leadership senior in finanza, strategia aziendale e sviluppo commerciale. In United Technologies (UTC), ha ricoperto il ruolo di CEO dal 2014 e presidente dal 2016, giocando un ruolo chiave nella fusione del 2020 che ha dato vita a RTX. In precedenza, è stato CFO di UTC dal 2008 al 2014.
Hayes è il quarto direttore indipendente aggiunto al consiglio di BD dal 2021, dimostrando l'impegno dell'azienda per il rinnovamento del consiglio e una solida governance aziendale.
BD (NYSE: BDX) ha nombrado a Gregory J. Hayes en su junta directiva, con efecto a partir del 26 de marzo de 2025. Hayes, de 64 años, actualmente se desempeña como presidente ejecutivo de RTX y aporta más de 30 años de experiencia ejecutiva. Esta designación se alinea con la estrategia de transformación de BD, especialmente mientras la empresa se prepara para la separación planificada de sus negocios de Soluciones Diagnósticas y Ciencias Biológicas.
El amplio historial de Hayes incluye roles de CEO y liderazgo senior en finanzas, estrategia corporativa y desarrollo empresarial. En United Technologies (UTC), se desempeñó como CEO desde 2014 y presidente desde 2016, desempeñando un papel clave en la fusión de 2020 que formó RTX. Anteriormente, fue CFO de UTC desde 2008 hasta 2014.
Hayes es el cuarto director independiente que se agrega a la junta de BD desde 2021, lo que demuestra el compromiso de la empresa con la renovación de la junta y una sólida gobernanza corporativa.
BD (NYSE: BDX)는 Gregory J. Hayes를 이사회에 임명했다고 발표했으며, 이는 2025년 3월 26일부터 효력이 발생합니다. 64세의 Hayes는 현재 RTX의 집행 회장으로 재직 중이며 30년 이상의 경영 경험을 보유하고 있습니다. 이번 임명은 BD의 변혁 전략과 일치합니다, 특히 회사가 진단 솔루션 및 생명과학 사업의 예정된 분리를 준비하는 과정에서 더욱 그렇습니다.
Hayes는 재무, 기업 전략 및 사업 개발 분야에서 CEO 및 고위 리더십 역할을 포함한 폭넓은 배경을 가지고 있습니다. 그는 United Technologies (UTC)에서 2014년부터 CEO로, 2016년부터 회장으로 재직하며 RTX를 형성한 2020년 합병에서 중요한 역할을 했습니다. 그는 2008년부터 2014년까지 UTC의 CFO로도 활동했습니다.
Hayes는 2021년 이후 BD 이사회에 추가된 네 번째 독립 이사로, 이는 회사의 이사회 갱신과 강력한 기업 거버넌스에 대한 의지를 보여줍니다.
BD (NYSE: BDX) a nommé Gregory J. Hayes au sein de son conseil d'administration, à compter du 26 mars 2025. Hayes, âgé de 64 ans, occupe actuellement le poste de président exécutif de RTX et apporte plus de 30 ans d'expérience en direction. Cette nomination s'inscrit dans la stratégie de transformation de BD, notamment alors que l'entreprise se prépare à la séparation prévue de ses activités de Solutions Diagnostiques et de Sciences de la Vie.
Le parcours varié de Hayes comprend des rôles de PDG et de direction senior dans les domaines des finances, de la stratégie d'entreprise et du développement commercial. Chez United Technologies (UTC), il a été PDG de 2014 à 2016 et président de 2016 à 2020, jouant un rôle clé dans la fusion de 2020 qui a formé RTX. Auparavant, il avait été CFO de UTC de 2008 à 2014.
Hayes est le quatrième directeur indépendant ajouté au conseil de BD depuis 2021, ce qui démontre l'engagement de l'entreprise en faveur du renouvellement du conseil et d'une gouvernance d'entreprise solide.
BD (NYSE: BDX) hat Gregory J. Hayes in seinen Vorstand berufen, mit Wirkung zum 26. März 2025. Hayes, 64 Jahre alt, ist derzeit als Executive Chairman von RTX tätig und bringt über 30 Jahre Führungserfahrung mit. Diese Ernennung steht im Einklang mit der Transformationsstrategie von BD, insbesondere während sich das Unternehmen auf die geplante Trennung seiner Diagnoselösungen und Biowissenschaften vorbereitet.
Hayes' umfangreicher Hintergrund umfasst CEO- und leitende Führungspositionen in den Bereichen Finanzen, Unternehmensstrategie und Geschäftsentwicklung. Bei United Technologies (UTC) war er von 2014 bis 2016 CEO und von 2016 bis 2020 Chairman und spielte eine Schlüsselrolle bei der Fusion 2020, die RTX bildete. Zuvor war er von 2008 bis 2014 CFO von UTC.
Hayes ist der vierte unabhängige Direktor, der seit 2021 in den Vorstand von BD aufgenommen wurde, was das Engagement des Unternehmens für die Erneuerung des Vorstands und eine starke Unternehmensführung zeigt.
- Planned strategic separation of Diagnostic Solutions and Biosciences business to unlock shareholder value
- Addition of experienced executive with proven track record in portfolio optimization and operational efficiency
- Strengthened board oversight with fourth independent director since 2021
- None.
Hayes, 64, is currently the executive chairman of the board of directors of RTX Corporation, the world's largest aerospace and defense company. He brings more than 30 years of extensive executive experience, having held chief executive officer and senior leadership roles across finance, corporate strategy and business development functions, as well as leadership of large and complex businesses undergoing transformative initiatives, including M&A and spinoff transactions. Hayes' appointment to the BD board of directors is in line with the company's ongoing commitment to strong corporate governance and regular board refreshment. With this appointment, the BD board of directors has added four new, independent directors since 2021.
"Greg will join the board at a pivotal time in BD's transformation, as we seek to unlock significant shareholder value through the planned separation of our Diagnostic Solutions and Biosciences business and launch of the 'New BD' as a medtech leader representing the foundation and future of health care," said Tom Polen, chairman, CEO and president of BD. "Greg's proven track record of portfolio optimization, strategic excellence and driving operational efficiency is well aligned with the BD Excellence operating system and our deep commitment to a culture of continuous improvement. He will be an invaluable asset to our board of directors and the future success of BD."
Prior to his appointment to the RTX board of directors, Hayes' career at United Technologies Corporation (UTC) spanned two decades, culminating in his appointment to chief executive officer in 2014 and chairman in 2016. As CEO, Hayes was instrumental in the formation of RTX — the result of the 2020 merger of UTC's aerospace businesses, Pratt & Whitney and Collins Aerospace, with Raytheon Company. Hayes, who joined UTC in 1999 through its merger with the Sundstrand Corporation, also served as UTC's chief financial officer from 2008 to 2014. He also serves on the board of directors for Phillips 66 Company.
"BD has a remarkable 125-year history as a leading manufacturer of medical devices and is critical to the infrastructure of our health care system," said Hayes. "We have an incredible opportunity ahead, and I look forward to leveraging my experience to help oversee a successful separation and establish 'New BD' as a differentiated and focused pure-play medtech company that is positioned to accelerate innovation, drive profitable growth and deliver long-term sustainable value for all stakeholders."
Hayes earned a bachelor's degree in Economics from Purdue University and is a certified public accountant.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.
Contacts:
| |
Media: | Investors: |
Troy Kirkpatrick | Adam Reiffe |
VP, Public Relations | Senior Director, Investor Relations |
858.617.2361 | 201.847.6927 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bd-names-gregory-j-hayes-to-board-of-directors-302412390.html
SOURCE BD (Becton, Dickinson and Company)
FAQ
What strategic changes is BDX implementing with Hayes' appointment?
How many new independent directors has BDX added since 2021?
What is Gregory Hayes' background before joining BDX's board?
How will the planned separation of BDX's businesses affect shareholders?
